CB-103 - Cellestia Biotech
https://oncologypro.esmo.org/meeting-resources/esmo-virtual-congress-2020/target-engagement-and-clinical-safety-of-cb-103-a-first-in-class-small-molecule-inhibitor-of-the-notch-transcription-complex
 
A.B. Azaro Pedrazzoli1; J.M. Perez Garcia2; J. Cortés3; E. Lopez Miranda4; I. Colombo5; E. Garralda6; D. Hess7; P.G. Nuciforo8; A. Vivancos9; R. Ferrarotto10; O. Schoenborn-Kellenberger11; K. Jorga12; M. Vigolo13; L. Beni14; R. Lehal14; M. Murone14; M. Bauer14; P. Pisa14; F.D. Vogl14; A. Stathis5
 
Jul 21, 2020
 
Prev Next